Meta Says States Seek $1.4 Trillion in Penalties Over Teen Social Media Addiction Lawsuit 
US Supreme Court Strikes Down Hawaii Gun Carry Law on Private Property 
Amy Coney Barrett Faces Conservative Backlash After Key Supreme Court Rulings Against Trump 
ECB's Kocher Says No Inflation Spillover Yet From Iran Conflict, Warns Risks Remain 
Japanese Yen Holds Steady as Intervention Hopes Grow Ahead of U.S. CPI Data 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
China Trade Surplus Hits $125.6 Billion as June Exports, Imports Smash Forecasts 
US Appeals Court Limits ICE Detention Without Bond Hearings After 90 Days 
Supreme Court Backs Lisa Cook, Defends Federal Reserve Independence Against Trump Firing Attempt 
Iraq PM Visits Washington as U.S. Oil, Gas Deals Take Center Stage 
European Stocks Slip as Middle East Tensions and Hormuz Threat Rattle Markets 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Trinidad Businessman Dominic Hadeed Appeals Detention Over Alleged Assassination Plot 
US Egg Producers Settle Price Manipulation Probe, Agree to Pay $3.3 Million and Donate 53 Million Eggs 
Australian Business Conditions Hold Steady as Easing Cost Pressures Face New Oil Price Risks 
Gold Prices Fall as US-Iran Conflict, Rising Oil Prices Fuel Fed Rate Concerns 
South Korea’s KOSPI Triggers Trading Curb as AI Chip Stock Selloff Deepens 
U.S. Bankruptcy Judge Michael Kaplan ruled that a Johnson & Johnson subsidiary can remain in bankruptcy, preventing plaintiffs from pursuing 38,000 lawsuits against it based on allegations that its products cause cancer.
J&J insists its talc is safe and is attempting to resolve the lawsuits by putting a recently formed subsidiary, LTL Management, into bankruptcy.
The legal maneuver is known as the "Texas two-step" that J&J employed allowed it to separate important assets from liabilities in a so-called divisive merger. LTL was formed in October 2021 by healthcare conglomerate J&J, which has a market value of more than $400 billion, filed for bankruptcy days later.
Plaintiffs argued that J&J's move was an abuse of the Chapter 11 system.
Kaplan rejected the plaintiffs' argument, saying that J&J’s approach was "unquestionably" proper and that bankruptcy offers a faster and more fair alternative to decades of litigation in other courts.
Jon Ruckdeschel, an attorney representing the plaintiffs in the talc lawsuits, said the ruling would be appealed, saying the bankruptcy code was never intended to be abused by massively profitable corporations as a means to delay or prevent cancer victims from having their day in court.
Talc plaintiffs and some critics had warned that the strategy could "open the floodgates" for other companies facing mass litigation risk.
The talc claimants and others had predicted that the approach would "raise the floodgates" for other corporations at risk of multiple litigations.
J&J faces claims from plaintiffs that its talc-based products caused ovarian cancer and mesothelioma, a form of cancer linked to asbestos exposure.
Before their filing, the business had already incurred costs of more than $3.5 billion in judgments and settlements, including one for more than $2 billion awarded against 22 women, according to bankruptcy court records.
Despite Johnson & Johnson setting aside $2 billion to settle talc claims, LTL executives characterized this as a "starting point" rather than a "cap" during court hearings last week.
LTL argued that bankruptcy was the only viable option to address the large number of lawsuits filed against J&J.
Last year, Johnson & Johnson began "Project Plato" to shift liability for its pending talc lawsuits to a newly established subsidiary that would subsequently be put into bankruptcy.
